Cargando…

Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients

Mutations in the SARS-CoV-2 Spike glycoprotein can affect monoclonal antibody efficacy. Recent findings report the occurrence of resistant mutations in immunocompromised patients after tixagevimab/cilgavimab treatment. More recently, the Food and Drug Agency revoked the authorization for tixagevimab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruber, Cesare Ernesto Maria, Tucci, Fabio Giovanni, Rueca, Martina, Mazzotta, Valentina, Gramigna, Giulia, Vergori, Alessandra, Fabeni, Lavinia, Berno, Giulia, Giombini, Emanuela, Butera, Ornella, Focosi, Daniele, Prandi, Ingrid Guarnetti, Chillemi, Giovanni, Nicastri, Emanuele, Vaia, Francesco, Girardi, Enrico, Antinori, Andrea, Maggi, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605390/ https://www.ncbi.nlm.nih.gov/pubmed/37892220 http://dx.doi.org/10.3390/biom13101538

Ejemplares similares

Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy
por: Rueca, Martina, et al.
Publicado: (2022)

Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022
por: Novazzi, Federica, et al.
Publicado: (2023)

SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods
por: Berno, Giulia, et al.
Publicado: (2022)

Genomic and Epidemiologic Surveillance of SARS-CoV-2 in the Pandemic Period: Sequencing Network of the Lazio Region, Italy
por: Rueca, Martina, et al.
Publicado: (2023)

Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant
por: Bordi, Licia, et al.
Publicado: (2023)

Structural Evolution of Delta (B.1.617.2) and Omicron (BA.1) Spike Glycoproteins
por: Prandi, Ingrid Guarnetti, et al.
Publicado: (2022)

Monkeypox virus in human body sites and fluids: evidence for transmission
por: Colavita, Francesca, et al.
Publicado: (2023)

The Spike Mutants Website: A Worldwide Used Resource against SARS-CoV-2
por: Romeo, Isabella, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis
por: Specchiarello, Eliana, et al.
Publicado: (2023)

Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein
por: Borocci, Stefano, et al.
Publicado: (2021)

Viral load decrease in SARS‐CoV‐2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents
por: Valentina, Mazzotta, et al.
Publicado: (2022)

Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021
por: Colavita, Francesca, et al.
Publicado: (2022)

Intact provirus and integration sites analysis in acute HIV-1 infection and changes after one year of early antiviral therapy
por: Rozera, Gabriella, et al.
Publicado: (2022)

Molecular Transmission Dynamics of Primary HIV Infections in Lazio Region, Years 2013–2020
por: Fabeni, Lavinia, et al.
Publicado: (2021)

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment
por: Focosi, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis
por: Mastrorosa, Ilaria, et al.
Publicado: (2022)

Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2023)

Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence
por: Alteri, Claudia, et al.
Publicado: (2018)

Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN Vaccine
por: Matusali, Giulia, et al.
Publicado: (2023)

What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis
por: Mastrorosa, Ilaria, et al.
Publicado: (2023)

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi
por: Zamprogna, Giulia, et al.
Publicado: (2023)

Tixagevimab + Cilgavimab: First Approval
por: Keam, Susan J.
Publicado: (2022)

Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysis
por: Sberna, Giuseppe, et al.
Publicado: (2022)

Viral replication and infectivity of monkeypox through semen – Authors' reply
por: Lapa, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
por: Vergori, Alessandra, et al.
Publicado: (2022)

Tixagevimab and cilgavimab for COVID-19 prophylaxis
Publicado: (2022)

Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
por: Mazzotta, Valentina, et al.
Publicado: (2022)

Structure of the stress-related LHCSR1 complex determined by an integrated computational strategy
por: Guarnetti Prandi, Ingrid, et al.
Publicado: (2022)

No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison
por: Gagliardini, Roberta, et al.
Publicado: (2021)

Tixagevimab/ Cilgavimab Outcomes Among Patients with Immunodeficiency
por: Sullivan, Juliana
Publicado: (2023)

Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH
por: Gagliardini, Roberta, et al.
Publicado: (2022)

Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
por: Colavita, Francesca, et al.
Publicado: (2023)

A Case of Severe Mpox Complicated with Streptococcus pyogenes Sepsis in a Patient with HIV Infection
por: Di Bari, Silvia, et al.
Publicado: (2023)

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies
por: Angotzi, Francesco, et al.
Publicado: (2023)

Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak
por: Mazzotta, V, et al.
Publicado: (2022)

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
por: Agrati, Chiara, et al.
Publicado: (2022)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2022)

Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia
por: Vergori, Alessandra, et al.
Publicado: (2021)

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
por: Levin, Myron J., et al.
Publicado: (2022)

Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections
por: Dichtl, Stefanie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qsop8s4opm0uhvlv9rukilgsis